Close
Nordic 9Nordic 9

Robert Laud (investor - Angel Investor)

Estonia
See something wrong or missing? Let us know
Offices:Talinn

Robert Laud is a CEO at Endover.

Average round investment:406.22k USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: Estonia Gearbox Biosciences
Mostly invests in: Estonia Estonia (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Robert Laud

Name Criteria
Estonia Siim Sikkut
83%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Estonia
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Estonia Johanna Britt Berzin
83%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Estonia
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Estonia Ivo Remmelg
83%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Estonia
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Hugues Flament
83%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Estonia
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Estonia UniTartu Ventures
82%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Estonia
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Poland Unfold.vc
80%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Genesis Biomed Ventures
80%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Sweden LIU Invest (Linköping University)
79%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Sweden Vasa Angels
79%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Denmark Accelerace
77%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top